SAB Biotherapeutics' Immunotherapy Proposal Among Top Platform Technology Solutions in WHO Report

News SAB Biotherapeutics' technology was the only immunotherapy platform among six finalists, which also included three vaccine platforms, a diagnostic technology and a technology covering all product streams. Contributed Author:  SAB Biotherapeutics, Inc. Topics:  Medical Diagnostics